Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Osamu Kaminuma

Showing results (1-10 of 127) with videos related to

Pageof 13
Sort By:
Inflammation & Allergy Drug Targets|May 14, 2008
Selective inhibitors of nuclear factor of activated T cells: potential therapeutic drugs for the treatment of immunological and inflammatory diseasesOsamu Kaminuma
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|September 1, 2022
[Preface]Osamu Kaminuma, Keitaro Hayashi
Biomolecules|April 23, 2022
Therapeutic Potential for Intractable Asthma by Targeting L-Type Amino Acid Transporter 1Keitaro Hayashi, Osamu Kaminuma
International Archives of Allergy and Immunology|June 18, 2002
Potential initiation of eosinophilic skin inflammation by antigen-specific T helper type 2 cellsOsamu Kaminuma, Akio Mori
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|November 2, 2020
[Preface]Osamu Kaminuma, Mayumi Saeki
Pathogens (Basel, Switzerland)|February 5, 2021
Sublingual Immunotherapy: How Sublingual Allergen Administration Heals Allergic Diseases; Current Perspective about the Mode of ActionMinoru Gotoh, Osamu Kaminuma
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|September 1, 2022
[Possible therapeutic use of L-type amino acid transporter 1 (LAT1)-specific inhibitor for intractable asthma treatment]Keitaro Hayashi, Osamu Kaminuma
International Journal of Molecular Sciences|April 3, 2021
Isoform-Selective NFAT Inhibitor: Potential Usefulness and DevelopmentNoriko Kitamura, Osamu Kaminuma
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|March 2, 2025
[Preface]Osamu Kaminuma, Keiko Yasumatsu
Nihon Rinsho. Japanese Journal of Clinical Medicine|September 17, 2005
[Inhibitors of NFAT-calcineurin pathway]Shoichiro Miyatake, Osamu Kaminuma
Pageof 13

Showing results (1-10 of 127) with videos related to

Sort By:
Pageof 13
Inflammation & Allergy Drug Targets|May 14, 2008
Selective inhibitors of nuclear factor of activated T cells: potential therapeutic drugs for the treatment of immunological and inflammatory diseasesOsamu Kaminuma
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|September 1, 2022
[Preface]Osamu Kaminuma, Keitaro Hayashi
Biomolecules|April 23, 2022
Therapeutic Potential for Intractable Asthma by Targeting L-Type Amino Acid Transporter 1Keitaro Hayashi, Osamu Kaminuma
International Archives of Allergy and Immunology|June 18, 2002
Potential initiation of eosinophilic skin inflammation by antigen-specific T helper type 2 cellsOsamu Kaminuma, Akio Mori
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|November 2, 2020
[Preface]Osamu Kaminuma, Mayumi Saeki
Pathogens (Basel, Switzerland)|February 5, 2021
Sublingual Immunotherapy: How Sublingual Allergen Administration Heals Allergic Diseases; Current Perspective about the Mode of ActionMinoru Gotoh, Osamu Kaminuma
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|September 1, 2022
[Possible therapeutic use of L-type amino acid transporter 1 (LAT1)-specific inhibitor for intractable asthma treatment]Keitaro Hayashi, Osamu Kaminuma
International Journal of Molecular Sciences|April 3, 2021
Isoform-Selective NFAT Inhibitor: Potential Usefulness and DevelopmentNoriko Kitamura, Osamu Kaminuma
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|March 2, 2025
[Preface]Osamu Kaminuma, Keiko Yasumatsu
Nihon Rinsho. Japanese Journal of Clinical Medicine|September 17, 2005
[Inhibitors of NFAT-calcineurin pathway]Shoichiro Miyatake, Osamu Kaminuma
Pageof 13